As we did not observe any discontinuation of treatment during the study period, it remains unclear whether pwIIH successfully treated with GLP-1-RAs sustain their weight loss, or a yo-yo effect occurs [44], which would pose an increased risk for a disease relapse
Currently, there is much interest in delivering GLP-1 receptor agonists via alternate, non-invasive routes with high bioavailability and least side effects as possible
The Effects of NLY01, a novel glucagon-like peptide-1 receptor agonist, on cuprizone-induced demyelination and remyelination: challenges and future perspectives
The most appropriate OGD duration and GSH concentration were determined by cell viability comparisons
Every cell contains NAD+ (Nicotinamide Adenine Dinucleotide) that plays a vital role in energy production, DNA repair, and cellular function
This process is called glycogenolysis and provides a short-term source of glucose when blood glucose levels are low, such as during an overnight fast or a bout of intense exercise (Matsui 2012
